가상 의료 보조 AI 시장 시장 규모, 성장 및 동향 분석 보고서 – 2030년까지의 세계 예측

AI in Virtual Health Assistants Market – Global Forecast to 2030

AI in Virtual Medical Assistants Market by Offering (Apps, EHR/EMR, IoT), Mode (Text, Multimodal, Avatar), Application (Workflow, Triage, RPM, Scheduling, Billing), End User, Use Case (Patient Access, Mental Health) & Region – Global Forecast to 2030

가상 의료 보조 AI 시장 – 제공 서비스(앱, EHR/EMR, IoT), 모드(텍스트, 멀티모달, 아바타), 적용 분야(워크플로우, 환자 분류, 원격 환자 관리, 예약, 청구), 최종 사용자, 사용 사례(환자 접근성, 정신 건강) 및 지역 – 2030년까지의 세계 예측

　　　　주문/문의　　　　조사회사/라이센스/납기안내

가상 의료 보조 AI 시장은 2025년 18억 6천만 달러 규모였으며, 2030년에는 88억 5천만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 36.6%의 성장률을 기록할 것으로 MarketsandMarkets는 전망하고 있습니다.
이러한 시장 성장은 AI 기술의 빠른 발전, 연중무휴 24시간 의료 서비스 접근성에 대한 수요 증가, 의료 시스템에 대한 부담 증가, 스마트폰 및 디지털 플랫폼의 보급 확대, 그리고 개인 맞춤형 및 예방적 치료에 대한 관심 증가에 힘입은 것입니다. 자연어 처리(NLP), 감정 인식, 전자건강기록(EHR) 통합과 같은 혁신 기술은 기능을 향상시키고 있으며, 전문 임상 지식 기반은 특히 종양학 및 당뇨병 관리 분야에서 질병 및 전문 분야별 맞춤형 치료를 지원하고 있습니다.

조사 범위

• 본 보고서는 제품, 상호 작용 방식, 애플리케이션, 최종 사용자 및 지역을 기준으로 가상 의료 보조 AI 시장을 분석합니다.
• 본 보고서는 시장 성장에 영향을 미치는 요인(동인, 제약, 기회 및 과제 등)을 분석합니다.
• 본 보고서는 이해관계자를 위한 시장 기회와 과제를 평가하고 시장 선도 기업의 경쟁 환경에 대한 자세한 정보를 제공합니다.
• 본 보고서는 성장 추세, 전망 및 글로벌 가상 의료 보조 AI 시장에 대한 기여도를 기준으로 마이크로 시장을 연구합니다.
• 본 보고서는 5대 주요 지역별 시장 부문의 매출을 예측합니다.

보고서 구매 이유

이 보고서는 기존 기업뿐만 아니라 신규 진입 기업/소규모 기업 모두에게 시장 동향을 파악하는 데 도움을 주어 시장 점유율 확대를 도모할 수 있도록 합니다. 보고서를 구매하는 기업은 다음 다섯 가지 전략 중 하나 또는 여러 가지를 조합하여 활용할 수 있습니다.

본 보고서는 다음과 같은 주요 사항에 대한 심층 분석을 제공합니다.

가상 의료 보조 AI 시장의 거시적 동향에 영향을 미치는 주요 동인(24시간 의료 서비스 수요 증가, 의료 시스템 부담 증가, AI 기술 발전, 스마트폰 및 디지털 플랫폼 사용 증가, 개인 맞춤형 및 예방 의료로의 전환), 제약 요인(데이터 개인정보 보호 및 보안 문제, 제한적인 임상 검증 및 신뢰도, AI 모델의 부정확성으로 인한 편향), 기회 요인(웨어러블 및 IoT 기기와의 AI 통합, 신흥 시장 및 의료 서비스 소외 계층), 그리고 과제 요인(규제 복잡성 및 분산, 책임 및 법적 책임)에 대한 분석.

• 제품 개발/혁신: 가상 의료 보조 AI 시장의 미래 기술, 연구 개발 활동 및 제품 출시에 대한 자세한 정보를 제공합니다.
• 시장 개발: 유망한 신흥 시장에 대한 종합적인 정보를 제공합니다. 본 보고서는 다양한 지역의 가상 의료 보조 AI 시장을 분석합니다.
• 시장 다각화: 인공지능 기반 가상 의료 보조 시장의 제품, 미개척 지역, 최근 개발 동향 및 투자에 대한 종합적인 정보 제공.
• 경쟁 분석: 인공지능 기반 가상 의료 보조 시장의 주요 업체들의 시장 점유율, 전략, 제품, 유통망 및 제조 역량에 대한 심층 분석.

Report Description

The AI in virtual medical assistants market was valued at USD 1.86 billion in 2025 and is estimated to reach USD 8.85 billion by 2030, registering a CAGR of 36.6% during the forecast period. Market growth is fueled by rapid AI advances, the growing need for 24/7 healthcare access, mounting pressure on healthcare systems, the widespread adoption of smartphones and digital platforms, and a shift toward personalized and preventive care. Innovations like natural language processing (NLP), emotion recognition, and EHR integration are improving functionality, while specialized clinical knowledge bases support disease- and specialty-specific care, especially in oncology and diabetes management.

Based on end user, the healthcare provider segment dominated the AI in virtual medical assistants market in 2024

The healthcare provider segment had the largest share of the AI in virtual medical assistants market in 2024. This is mainly driven by the increasing need to improve clinical efficiency and patient engagement while reducing administrative workloads. Healthcare providers are more frequently adopting AI-powered virtual assistants to streamline appointment scheduling, medical documentation, triage, and patient communication. This allows physicians and staff to focus more on direct patient care, improve workflow management, lower costs, and support better clinical decision-making. As a result, adoption in this segment continues to grow.

By offering EHR/EMR integrated systems, it is expected to be the fastest growing segment during the study period.

The rapid growth of the EHR/EMR integrated systems segment is fueled by the rising need for seamless interoperability and unified access to patient data across healthcare networks. Incorporating AI-enabled virtual medical assistants into EHR/EMR platforms enables automated documentation, real-time clinical decision support, and personalized patient engagement based on comprehensive health records. This not only improves care coordination and workflow efficiency but also helps ensure regulatory compliance and supports value-based care initiatives, thereby increasing demand for EHR/EMR integrated systems in AI-powered virtual medical assistants market.

The North American market accounted for the largest share of the AI in virtual medical assistants market in 2024.

North America is experiencing significant growth in AI-enabled virtual medical assistants (VHAs), driven by increasing demand for convenient digital healthcare services such as symptom checking, appointment scheduling, and medication management. Healthcare professional shortages are further speeding up adoption, as VHAs help streamline workflows, triage patients, and handle routine interactions. Advances in NLP, machine learning, and conversational AI are enhancing their accuracy and reliability, increasing trust among providers and patients. Integration with wearables and remote monitoring offers real-time health insights and proactive care, while the growing focus on mental and behavioral health is broadening their use in stress management and therapy adherence. Additionally, financial pressures to cut costs and the continued adoption of telehealth after the pandemic are solidifying VHAs as essential tools for care coordination, patient engagement, and digital healthcare delivery.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the AI in virtual medical assistants market.

The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation – C-level (44%), Directors (31%), and Others (25%)
• By Region – North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), Middle East & Africa (3%)

Key Players in the AI in Virtual Medical Assistants Market

Prominent players in the AI in virtual medical assistants market include Microsoft (US), Verint Systems (US), Amazon.com, Inc. (US), Infermendica (Poland), Salesforce, Inc. (US), Teckel Medical (Spain), eGain Corporation (US), Teladoc Health, Inc. (US), Fabric Labs (US), Teladoc Health, Inc. (US), Movate (US), Feebris (UK), Healthtap, Inc.(US), ADA health(Germany), Buoy Health(US), Woebot Health(US),, Wysa Ltd.(US), Well Health Technologies Corp (Canada), Healthily (UK), Orbita, Inc. (US), 5 Health holdings Inc (Singapore), Hyro AI Inc (US), Empower Health(US), Veradigm LLC (US), K Health (US).

Market players are focusing on both organic and inorganic growth strategies, such as product launches and improvements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, contracts, and alliances, to broaden their offerings, meet unmet customer needs, increase profitability, and expand their presence in the global market.

The study includes an in-depth competitive analysis of these key players in the AI in virtual medical assistants market, with their company profiles, recent developments, and key market strategies.

Research Coverage

• The report studies the AI in virtual medical assistants market based on offerings, mode of interaction, application, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the global AI in virtual medical assistants market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the following five strategies.

This report provides insights into the following pointers:

Analysis of key drivers (rising demand for 24/7 healthcare, growing pressure on healthcare system, advancements in AI technologies, increasing use of smartphones and digital platforms, shift towards personalized and preventive care), restraints (data privacy and security concerns, limited clinical validation and trust, Bias in inaccuracy in AI models), opportunities (AI integration with wearables and IOT devices, emerging markets and underserved populations,), and challenges (regulatory complexity and fragmentation, accountability and legal liability) influencing the industry macro dynamics of AI in virtual medical assistants market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the AI in virtual medical assistants market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the AI in virtual medical assistants across varied regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the AI in virtual medical assistants market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the AI in virtual medical assistants market.

Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.4 CURRENCY 37
1.5 LIMITATIONS 38
1.6 STAKEHOLDERS 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
2.1.1 SECONDARY RESEARCH 40
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY RESEARCH 42
2.1.2.1 Primary sources 42
2.1.2.2 Key data from primary sources 43
2.1.2.3 Breakdown of primaries 43
2.1.2.4 Insights from primary experts 44
2.2 RESEARCH METHODOLOGY DESIGN 44
2.3 MARKET SIZE ESTIMATION 46
2.4 DATA TRIANGULATION 50
2.5 MARKET SHARE ESTIMATION 50
2.6 STUDY ASSUMPTIONS 51
2.7 RESEARCH LIMITATIONS 51
2.7.1 METHODOLOGY-RELATED LIMITATIONS 51
2.8 RISK ASSESSMENT 52
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 57
4.1 AI IN VIRTUAL HEALTH ASSISTANTS MARKET OVERVIEW 57
4.2 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION & COUNTRY 58
4.3 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: GEOGRAPHIC SNAPSHOT 59
4.4 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: DEVELOPED VS. EMERGING ECONOMIES 60

5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
5.2.1 DRIVERS 62
5.2.1.1 Rising demand for 24/7 healthcare access 62
5.2.1.2 Growing pressure on healthcare systems 63
5.2.1.3 Increasing use of smartphones and digital platforms 63
5.2.1.4 Shift toward personalized & preventive care 64
5.2.1.5 Support for mental health & chronic care 64
5.2.2 RESTRAINTS 65
5.2.2.1 Data privacy and security concerns 65
5.2.2.2 Limited clinical validation and trust 65
5.2.2.3 Bias and inaccuracy in Al models 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Al integration with wearables and IoT devices 66
5.2.3.2 Emerging markets and underserved populations 67
5.2.4 CHALLENGES 67
5.2.4.1 Regulatory complexity and fragmentation 67
5.2.4.2 User engagement and retention 68
5.2.4.3 Accountability and legal liability 68
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
5.4 INDUSTRY TRENDS 70
5.4.1 SHIFT TOWARD MULTIMODAL INTERACTION 70
5.4.2 USE OF GENERATIVE AI FOR HUMAN-LIKE CONVERSATIONS 70
5.4.3 RISE OF AI-POWERED VIRTUAL NURSES & AVATARS 70
5.5 ECOSYSTEM ANALYSIS 70
5.6 SUPPLY CHAIN ANALYSIS 74
5.7 TECHNOLOGY ANALYSIS 76
5.7.1 KEY TECHNOLOGIES 76
5.7.1.1 Natural language processing (NLP) 76
5.7.1.2 Speech recognition and voice AI 77
5.7.1.3 Machine learning (ML) and deep learning 77
5.7.1.4 API and cloud integration 77
5.7.1.5 Generative AI and large language models (LLMS) 77
5.7.1.6 Avatars and embodied conversational agents (ECAS) 78
5.7.1.7 Conversational AI 78
5.7.2 COMPLEMENTARY TECHNOLOGIES 79
5.7.2.1 Electronic health record (EHR) systems 79
5.7.2.2 Wearable and Internet of Things (IOT) devices 79
5.7.2.3 Remote patient monitoring (RPM) tools 79
5.7.2.4 Speech emotion recognition (SER) 79
5.7.3 ADJACENT TECHNOLOGIES 80
5.7.3.1 Digital therapeutics (DTX) 80
5.7.3.2 Augmented reality (AR) and virtual reality (VR) 80
5.8 REGULATORY ANALYSIS 80
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.8.2 REGULATORY ANALYSIS 83
5.9 PRICING ANALYSIS 86
5.9.1 INDICATIVE PRICE FOR AI IN VIRTUAL HEALTH ASSISTANTS, BY KEY PLAYER (2024) 87
5.9.2 INDICATIVE PRICE FOR AI IN VIRTUAL HEALTH ASSISTANTS, BY REGION (2024) 88
5.9.3 PRICING MODELS (QUALITATIVE) 89
5.10 PORTER’S FIVE FORCES ANALYSIS 90
5.10.1 THREAT OF NEW ENTRANTS 91
5.10.2 THREAT OF SUBSTITUTES 91
5.10.3 BARGAINING POWER OF BUYERS 92
5.10.4 BARGAINING POWER OF SUPPLIERS 92
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 92
5.11 PATENT ANALYSIS 92
5.11.1 PATENT PUBLICATION TRENDS FOR AI IN VIRTUAL HEALTH ASSISTANT SOLUTIONS 92
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 93
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.12.2 BUYING CRITERIA 97
5.13 END-USER ANALYSIS 98
5.13.1 UNMET NEEDS 98
5.13.2 END-USER EXPECTATIONS 99
5.14 KEY CONFERENCES & EVENTS, 2025–2026 100
5.14.1 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 100
5.15 CASE STUDY ANALYSIS 101
5.15.1 TRANSFORMING PATIENT ACCESS WITH AI-DRIVEN VIRTUAL ASSISTANTS 101
5.15.1.1 Case 1: Reducing operational costs and improving access with Fabric’s Clare at OSF HealthCare 101
5.15.2 ENHANCING PATIENT ACCESS AND EFFICIENCY THROUGH AI-DRIVEN CARE NAVIGATION 102
5.15.2.1 Case 2: Demonstrating threefold return on investment and enhanced care access through Fabric’s AI-enabled virtual assistant at Endeavor Health 102
5.15.3 ADVANCING EQUITABLE CARE ACCESS THROUGH AI-POWERED PATIENT NAVIGATION 102
5.15.3.1 Case 3: Reducing access barriers and strengthening community health with Fabric’s conversational AI at MLKCH 102
5.15.4 ENHANCING MENTAL HEALTH SUPPORT THROUGH AI-POWERED VIRTUAL ASSISTANTS 103
5.15.4.1 Case 4: Expanding access to mental health support via Wysa’s
AI-enabled virtual assistant in NHS talking therapies 103
5.16 INVESTMENT & FUNDING SCENARIO 104
5.17 BUSINESS MODEL ANALYSIS 104
5.17.1 LICENSE-BASED BUSINESS MODELS 104
5.17.2 SUBSCRIPTION-BASED BUSINESS MODELS 104
5.17.3 SOFTWARE-AS-A-SERVICE (SAAS) BUSINESS MODELS 104
5.17.4 PAY-PER-USE BUSINESS MODELS 105
5.17.5 FREEMIUM BUSINESS MODELS 105
5.17.6 INTEGRATED SERVICE AND SOFTWARE BUNDLE BUSINESS MODELS 105
5.17.7 OUTCOME-BASED OR VALUE-BASED BUSINESS MODELS 105
5.17.8 SOFTWARE AS A MEDICAL DEVICE (SAMD) BUSINESS MODELS 105
5.18 IMPACT OF AI/GEN AI ON AI IN VIRTUAL HEALTH ASSISTANTS MARKET 106
5.18.1 KEY USE CASES 107
5.18.2 CASE STUDIES 108
5.18.2.1 Case Study 1: Generative AI-powered conversational agent for appointment management at MLK Community Healthcare (MLKCH) 108
5.18.2.2 Case Study 2: Generative AI-driven multilingual VHA for chronic disease management at large Southeast Asian health system 109
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 109
5.18.3.1 AI in patient engagement & support platforms 110
5.18.3.2 AI in healthcare operations & management tools 110
5.18.3.3 AI in personalized health & wellness coaching 110
5.18.4 USER READINESS & IMPACT ASSESSMENT 110
5.18.4.1 User readiness 110
5.18.4.1.1 User A: Patients 110
5.18.4.1.2 User B: Healthcare providers 110
5.18.4.1.3 User C: Healthcare payers 111
5.18.4.2 Impact assessment 111
5.18.4.2.1 User A: Patients 111
5.18.4.2.1.1 Implementation 111
5.18.4.2.1.2 Impact 111
5.18.4.2.2 User B: Healthcare providers 111
5.18.4.2.2.1 Implementation 111
5.18.4.2.2.2 Impact 112
5.18.4.2.3 User C: Healthcare payers 112
5.18.4.2.3.1 Implementation 112

5.19 IMPACT OF 2025 US TARIFFS ON AI IN VIRTUAL HEALTH ASSISTANTS MARKET 112
5.19.1 INTRODUCTION 112
5.19.2 KEY TARIFF RATES 114
5.19.3 PRICE IMPACT ANALYSIS 115
5.19.4 IMPACT ON COUNTRY/REGION 118
5.19.4.1 US 118
5.19.4.2 Europe 118
5.19.4.3 Asia Pacific 118
5.19.5 IMPACT ON END-USE INDUSTRIES 119
6 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING 120
6.1 INTRODUCTION 121
6.2 MOBILE APPLICATIONS 121
6.2.1 WIDESPREAD ADOPTION OF MOBILE APPLICATIONS TO SUPPORT MARKET GROWTH 121
6.3 SMART SPEAKERS & IOT/WEARABLE-CONNECTED DEVICES 122
6.3.1 GROWING USE OF WEARABLES FOR HEALTH AND FITNESS TRACKING TO DRIVE MARKET GROWTH 122
6.4 WEB-BASED PLATFORMS 124
6.4.1 ABILITY OF WEB PLATFORMS TO SERVE AS SCALABLE CHANNELS FOR VIRTUAL ASSISTANTS TO BOOST GROWTH 124
6.5 EHR/EMR-INTEGRATED SYSTEMS 125
6.5.1 ABILITY OF EHR/EMR TO EMBED AI VIRTUAL HEALTH ASSISTANTS DIRECTLY INTO EVERYDAY CLINICAL PRACTICE TO FUEL MARKET 125
7 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION 127
7.1 INTRODUCTION 128
7.2 TEXT-BASED INTERACTION 128
7.2.1 ACCESSIBLE, SCALABLE, AND USER-FRIENDLY VIRTUAL INTERACTIONS ASSOCIATED WITH TEXT-BASED AI ASSISTANTS TO BOOST GROWTH 128
7.3 VOICE-BASED INTERACTION 130
7.3.1 NEED FOR ACCESSIBLE, INTUITIVE, AND HANDS-FREE HEALTHCARE SOLUTIONS TO DRIVE DEMAND FOR VOICE-BASED INTERACTION 130
7.4 MULTIMODAL INTERACTION 131
7.4.1 INCREASING DIGITAL ADOPTION AMONG PATIENTS AND PROVIDERS TO DRIVE MULTIMODAL VHA DEPLOYMENT 131
7.5 AVATAR/EMOTION-AWARE AI 133
7.5.1 ADVANCING PATIENT ENGAGEMENT THROUGH AVATAR-BASED AND EMOTION-AWARE AI TO BOOST MARKET 133

8 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION 135
8.1 INTRODUCTION 136
8.2 CLINICAL APPLICATIONS 136
8.2.1 SYMPTOM ASSESSMENT & TRIAGE 138
8.2.1.1 Ability to strengthen digital front-door capabilities by streamlining patient flow to drive demand 138
8.2.2 PATIENT INTAKE & HISTORY COLLECTION 139
8.2.2.1 Advantages such as accurate, standardized data capture for effective diagnosis and treatment planning to boost market 139
8.2.3 MEDICATION MANAGEMENT & REMINDERS 140
8.2.3.1 Safe, accurate, and personalized treatment pathways to drive adoption 140
8.2.4 CLINICAL DECISION SUPPORT 141
8.2.4.1 Ability to leverage evidence-based insights to improve diagnostic accuracy and treatment outcomes to fuel growth 141
8.2.5 CLINICAL WORKFLOW ASSISTANCE 142
8.2.5.1 Advantages such as streamlined processes, optimized resources, and timely care delivery to drive demand 142
8.2.6 REHABILITATION & RECOVERY TRACKING 143
8.2.6.1 Improved post-treatment outcomes to propel market 143
8.2.7 REMOTE PATIENT MONITORING 144
8.2.7.1 Continuous tracking of vital signs and chronic conditions beyond hospital settings to support market growth 144
8.2.8 OPERATIVE CARE GUIDANCE 145
8.2.8.1 Real-time support, predictive insights, and standardized workflows to drive adoption 145
8.2.9 HEALTH EDUCATION & AWARENESS 146
8.2.9.1 Personalized insights, evidence-based guidance, and interactive support to strengthen engagement with patients 146
8.2.10 WELLNESS & LIFESTYLE COACHING 147
8.2.10.1 Personalized guidance, behavioral support, and continuous motivation to promote long-term health and well-being 147
8.3 NON-CLINICAL APPLICATIONS 148
8.3.1 VIRTUAL FRONT DESK/SCHEDULING 150
8.3.1.1 Advantages such as streamlining patient access and reducing administrative inefficiencies to drive growth 150
8.3.2 PATIENT ONBOARDING & NAVIGATING 151
8.3.2.1 AI-powered onboarding and navigation to enhance engagement and retention 151
8.3.3 AI MEDICAL SCRIBING 152
8.3.3.1 Enhanced clinical documentation efficiency through AI-powered medical scribing to boost market 152
8.3.4 AI-DRIVEN BILLING & CLAIMS PROCESSING 153
8.3.4.1 Optimizing revenue cycle efficiency through AI-enabled billing and claims processing to fuel growth 153
8.3.5 WORKFORCE/STAFF ASSISTANCE 154
8.3.5.1 Enhanced workforce efficiency and staff support through AI-driven virtual assistance to support market 154
9 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER 156
9.1 INTRODUCTION 157
9.2 HEALTHCARE PROVIDERS 157
9.2.1 HOSPITALS & CLINICS 159
9.2.1.1 Growing integration of AI-enabled virtual health assistants to enhance care delivery in hospitals & clinics 159
9.2.2 AMBULATORY CARE CENTERS 160
9.2.2.1 Ability of AI-enabled virtual assistants to drive efficiency and patient flow in ambulatory care services to boost market 160
9.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 161
9.2.3.1 Ability of intelligent virtual assistants to support proactive care and safety in long-term care settings to fuel growth 161
9.2.4 HOME HEALTHCARE 162
9.2.4.1 Ability of AI-based virtual health assistants to streamline monitoring of healthcare in home settings to propel growth 162
9.2.5 OTHER HEALTHCARE PROVIDERS 163
9.3 HEALTHCARE PAYERS 164
9.3.1 COST-EFFECTIVE, PREVENTIVE, AND PERSONALIZED CARE THROUGH AI-POWERED VIRTUAL HEALTH ASSISTANTS TO SUPPORT GROWTH 164
9.4 PATIENTS 165
9.4.1 ADVANTAGES OF AI-POWERED VIRTUAL HEALTH ASSISTANTS SUCH AS ACCESSIBLE AND PERSONALIZED CARE TO DRIVE ADOPTION 165
9.5 OTHER END USERS 167
10 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY REGION 168
10.1 INTRODUCTION 169
10.2 NORTH AMERICA 170
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171
10.2.2 US 176
10.2.2.1 Rising demand for personalized, accessible, and AI-driven healthcare to drive market growth 176
10.2.3 CANADA 180
10.2.3.1 Rising chronic disease burden and digital health transformation to drive market growth 180

10.3 EUROPE 184
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 185
10.3.2 GERMANY 190
10.3.2.1 Leveraging digital health policy and DIGA reforms to accelerate AI virtual assistant adoption 190
10.3.3 FRANCE 194
10.3.3.1 Advancement in French-language NLP and institutional AI support to drive market growth 194
10.3.4 UK 198
10.3.4.1 National interoperability standards to drive system-wide integration 198
10.3.5 ITALY 202
10.3.5.1 Growing number of national AI research hubs focused on healthcare ethics and explainability to boost market 202
10.3.6 SPAIN 206
10.3.6.1 Strong emphasis on emotional AI and psychological wellbeing tools to advance virtual health assistant capabilities 206
10.3.7 REST OF EUROPE 210
10.4 ASIA PACIFIC 214
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 215
10.4.2 CHINA 220
10.4.2.1 Healthcare digitization and AI sovereignty to drive market growth 220
10.4.3 JAPAN 224
10.4.3.1 Technological sophistication and aging demographics to propel virtual health assistants market growth 224
10.4.4 INDIA 228
10.4.4.1 Rising population and healthcare burden to fuel demand for scalable AI virtual health assistant solutions 228
10.4.5 REST OF ASIA PACIFIC 232
10.5 LATIN AMERICA 236
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 236
10.5.2 BRAZIL 241
10.5.2.1 Advancing AI-driven virtual care to contribute to market growth 241
10.5.3 MEXICO 245
10.5.3.1 Leveraging AI-powered virtual health assistants to address systemic healthcare gaps to drive growth 245
10.5.4 REST OF LATIN AMERICA 249
10.6 MIDDLE EAST & AFRICA 253
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 254
10.6.2 GCC COUNTRIES 259
10.6.2.1 National AI agendas, workforce shortages, and multilingual needs to drive demand for AI-powered virtual health assistants 259
10.6.3 REST OF MIDDLE EAST & AFRICA 262

11 COMPETITIVE LANDSCAPE 267
11.1 OVERVIEW 267
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 267
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN VIRTUAL HEALTH ASSISTANTS MARKET 268
11.3 REVENUE ANALYSIS, 2020–2024 270
11.4 MARKET SHARE ANALYSIS, 2024 271
11.5 BRAND/PRODUCT COMPARISON 274
11.6 COMPANY VALUATION & FINANCIAL METRICS 275
11.6.1 FINANCIAL METRICS 275
11.6.2 COMPANY VALUATION 275
11.7 MARKET RANKING ANALYSIS 276
11.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 276
11.8.1 STARS 277
11.8.2 EMERGING LEADERS 277
11.8.3 PERVASIVE PLAYERS 277
11.8.4 PARTICIPANTS 277
11.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 279
11.8.5.1 Company footprint 279
11.8.5.2 Region footprint 280
11.8.5.3 Offering footprint 281
11.8.5.4 Mode of interaction footprint 282
11.8.5.5 Application footprint 283
11.8.5.6 End-user footprint 284
11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 285
11.9.1 PROGRESSIVE COMPANIES 285
11.9.2 RESPONSIVE COMPANIES 285
11.9.3 DYNAMIC COMPANIES 285
11.9.4 STARTING BLOCKS 285
11.9.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 287
11.9.5.1 Detailed list of key startups/SMEs 287
11.9.5.2 Competitive benchmarking of startups/SMEs 287
11.10 COMPETITIVE SCENARIO 288
11.10.1 PRODUCT LAUNCHES & APPROVALS 288
11.10.2 DEALS 290
11.10.3 EXPANSIONS 291
11.10.4 OTHER DEVELOPMENTS 292

12 COMPANY PROFILES 293
12.1 KEY PLAYERS 293
12.1.1 TELADOC HEALTH, INC. 293
12.1.1.1 Business overview 293
12.1.1.2 Products offered 294
12.1.1.3 Recent developments 295
12.1.1.3.1 Product launches 295
12.1.1.3.2 Deals 296
12.1.1.4 MnM view 297
12.1.1.4.1 Right to win 297
12.1.1.4.2 Strategic choices 297
12.1.1.4.3 Weaknesses & competitive threats 298
12.1.2 MICROSOFT (NUANCE COMMUNICATIONS INC.) 299
12.1.2.1 Business overview 299
12.1.2.2 Products offered 300
12.1.2.3 Recent developments 302
12.1.2.3.1 Product launches 302
12.1.2.3.2 Deals 303
12.1.2.4 MnM view 303
12.1.2.4.1 Right to win 303
12.1.2.4.2 Strategic choices 304
12.1.2.4.3 Weaknesses & competitive threats 304
12.1.3 AMAZON.COM INC. 305
12.1.3.1 Business overview 305
12.1.3.2 Products offered 307
12.1.3.3 Recent developments 307
12.1.3.3.1 Product launches 307
12.1.3.3.2 Deals 308
12.1.3.4 MnM view 308
12.1.3.4.1 Right to win 308
12.1.3.4.2 Strategic choices 309
12.1.3.4.3 Weaknesses & competitive threats 309
12.1.4 SALESFORCE, INC. 310
12.1.4.1 Business overview 310
12.1.4.2 Products offered 311
12.1.4.3 Recent developments 312
12.1.4.3.1 Product launches & upgrades 312
12.1.4.3.2 Deals 313
12.1.4.4 MnM view 314
12.1.4.4.1 Right to win 314
12.1.4.4.2 Strategic choices 314
12.1.4.4.3 Weaknesses & competitive threats 315
12.1.5 INFERMEDICA 316
12.1.5.1 Business overview 316
12.1.5.2 Products offered 316
12.1.5.3 Recent developments 317
12.1.5.3.1 Product launches 317
12.1.5.3.2 Deals 317
12.1.5.3.3 Expansions 318
12.1.5.4 MnM view 318
12.1.5.4.1 Right to win 318
12.1.5.4.2 Strategic choices 319
12.1.5.4.3 Weaknesses & competitive threats 319
12.1.6 EGAIN CORPORATION 320
12.1.6.1 Business overview 320
12.1.6.2 Products offered 322
12.1.6.3 Recent developments 323
12.1.6.3.1 Product launches 323
12.1.6.4 MnM view 323
12.1.6.4.1 Right to win 323
12.1.6.4.2 Strategic choices 323
12.1.6.4.3 Weaknesses & competitive threats 324
12.1.7 VERINT SYSTEMS INC. 325
12.1.7.1 Business overview 325
12.1.7.2 Products offered 327
12.1.7.3 Recent developments 328
12.1.7.3.1 Product launches 328
12.1.7.3.2 Deals 328
12.1.7.4 MnM view 329
12.1.7.4.1 Right to win 329
12.1.7.4.2 Strategic choices 329
12.1.7.4.3 Weaknesses & competitive threats 329
12.1.8 LIVEPERSON 330
12.1.8.1 Business overview 330
12.1.8.2 Products offered 332
12.1.8.3 Recent developments 333
12.1.8.3.1 Product launches 333
12.1.8.3.2 Deals 334
12.1.8.4 MnM view 334
12.1.8.4.1 Right to win 334
12.1.8.4.2 Strategic choices 334
12.1.8.4.3 Weaknesses & competitive threats 335

12.1.9 NICE 336
12.1.9.1 Business overview 336
12.1.9.2 Products offered 337
12.1.9.3 Recent developments 338
12.1.9.3.1 Product launches & upgrades 338
12.1.9.3.2 Deals 339
12.1.9.4 MnM view 340
12.1.9.4.1 Right to win 340
12.1.9.4.2 Strategic choices 340
12.1.9.4.3 Weaknesses & competitive threats 341
12.1.10 TECKEL MEDICAL 342
12.1.10.1 Business overview 342
12.1.10.2 Products offered 342
12.1.10.3 Recent developments 343
12.1.10.3.1 Product launches 343
12.1.10.3.2 Deals 343
12.1.10.3.3 Other developments 345
12.1.10.4 MnM view 345
12.1.10.4.1 Right to win 345
12.1.10.4.2 Strategic choices 346
12.1.10.4.3 Weaknesses & competitive threats 346
12.1.11 MOVATE 347
12.1.11.1 Business overview 347
12.1.11.2 Products offered 347
12.1.11.3 Recent developments 348
12.1.11.3.1 Product launches 348
12.1.11.3.2 Deals 349
12.1.12 FEEBRIS LTD. 350
12.1.12.1 Business overview 350
12.1.12.2 Products offered 351
12.1.12.3 Recent developments 351
12.1.12.3.1 Product launches 351
12.1.12.3.2 Deals 352
12.1.13 HEALTHTAP, INC. 353
12.1.13.1 Business overview 353
12.1.13.2 Products offered 354
12.1.13.3 Recent developments 354
12.1.13.3.1 Product launches 354
12.1.13.3.2 Deals 355

12.1.14 ADA HEALTH 356
12.1.14.1 Business overview 356
12.1.14.2 Products offered 357
12.1.14.3 Recent developments 357
12.1.14.3.1 Product approvals 357
12.1.14.3.2 Deals 358
12.1.15 BUOY HEALTH, INC. 360
12.1.15.1 Business overview 360
12.1.15.2 Products offered 361
12.1.15.3 Recent developments 362
12.1.15.3.1 Product launches 362
12.1.15.3.2 Deals 362
12.1.16 WOEBOT HEALTH 364
12.1.16.1 Business overview 364
12.1.16.2 Products offered 365
12.1.16.3 Recent developments 365
12.1.16.3.1 Deals 365
12.1.16.3.2 Other developments 366
12.1.17 FABRIC LABS, INC. (GYANT) 367
12.1.17.1 Business overview 367
12.1.17.2 Products offered 368
12.1.17.3 Recent developments 369
12.1.17.3.1 Product launches 369
12.1.17.3.2 Deals 370
12.1.17.3.3 Other developments 371
12.1.18 WYSA LTD. 372
12.1.18.1 Business overview 372
12.1.18.2 Products offered 373
12.1.18.3 Recent developments 374
12.1.18.3.1 Product launches 374
12.1.18.3.2 Deals 375
12.1.19 WELL HEALTH TECHNOLOGIES CORP 376
12.1.19.1 Business overview 376
12.1.19.2 Products offered 377
12.1.19.3 Recent developments 378
12.1.19.3.1 Product launches 378
12.1.19.3.2 Deals 380
12.1.20 HEALTHILY LTD 381
12.1.20.1 Business overview 381
12.1.20.2 Products offered 382
12.1.20.3 Recent developments 382
12.1.20.3.1 Product launches & upgrades 382
12.1.20.3.2 Deals 383
12.1.21 ORBITA, INC. 385
12.1.21.1 Business overview 385
12.1.21.2 Products offered 386
12.1.21.3 Recent developments 387
12.1.21.3.1 Product launches 387
12.1.21.3.2 Deals 387
12.1.22 5 HEALTH HOLDINGS INC 389
12.1.22.1 Business overview 389
12.1.22.2 Products offered 390
12.1.22.3 Recent developments 391
12.1.22.3.1 Deals 391
12.1.23 HYRO AI INC. 392
12.1.23.1 Business overview 392
12.1.23.2 Products offered 393
12.1.23.3 Recent developments 394
12.1.23.3.1 Product launches 394
12.1.23.3.2 Deals 394
12.1.24 EMPOWER HEALTH 396
12.1.24.1 Business overview 396
12.1.24.2 Products offered 397
12.1.24.3 Recent developments 397
12.1.24.3.1 Product launches 397
12.1.24.3.2 Deals 398
12.1.25 VERADIGM LLC 399
12.1.25.1 Business overview 399
12.1.25.2 Products offered 401
12.1.25.3 Recent developments 402
12.1.25.3.1 Product launches 402
12.1.25.3.2 Deals 402
12.1.26 K HEALTH 403
12.1.26.1 Business overview 403
12.1.26.2 Products offered 403
12.1.26.3 Recent developments 405
12.1.26.3.1 Deals 405
12.2 OTHER PLAYERS 406
12.2.1 SULLY AI 406
12.2.2 MEDVA 407
12.2.3 HEIDI 408
12.2.4 DOCTRONIC INC. 409
12.2.5 EMPARA 410
13 APPENDIX 411
13.1 DISCUSSION GUIDE 411
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 416
13.3 CUSTOMIZATION OPTIONS 418
13.4 RELATED REPORTS 418
13.5 AUTHOR DETAILS 419

LIST OF TABLES

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38
TABLE 2 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: RISK ASSESSMENT 52
TABLE 3 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: IMPACT ANALYSIS 62
TABLE 4 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: ROLE IN ECOSYSTEM 73
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 8 REGULATORY STANDARDS FOR AI IN VIRTAL HEALTH ASSISTANTS 83
TABLE 9 REGULATORY REQUIREMENTS IN NORTH AMERICA 83
TABLE 10 REGULATORY REQUIREMENTS IN EUROPE 84
TABLE 11 REGULATORY REQUIREMENTS IN ASIA PACIFIC 85
TABLE 12 REGULATORY REQUIREMENTS IN LATIN AMERICA 86
TABLE 13 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 86
TABLE 14 INDICATIVE PRICE OF AI IN VIRTUAL HEALTH ASSISTANTS, BY KEY PLAYER (2024) 87
TABLE 15 AVERAGE SELLING PRICE OF AI TRIAGE SOFTWARE 88
TABLE 16 INDICATIVE PRICE FOR AI IN VIRTUAL HEALTH ASSISTANTS, BY REGION (2024) 89
TABLE 17 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 91
TABLE 18 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN VIRTUAL HEALTH ASSISTANT SOLUTIONS 93
TABLE 19 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: LIST OF PATENTS/PATENT APPLICATIONS 95
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 97
TABLE 21 KEY BUYING CRITERIA FOR END USERS 97
TABLE 22 UNMET NEED IN AI IN VIRTUAL HEALTH ASSISTANT SOLUTIONS 98
TABLE 23 END-USER EXPECTATIONS IN AI IN VIRTUAL HEALTH ASSISTANTS MARKET 99
TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 114
TABLE 25 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 121
TABLE 26 MOBILE APPLICATIONS: MAJOR PLAYERS AND OFFERINGS 122
TABLE 27 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR MOBILE APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 122
TABLE 28 SMART SPEAKERS & IOT/WEARABLE-CONNECTED DEVICES: MAJOR PLAYERS AND OFFERINGS 123
TABLE 29 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR SMART SPEAKERS & IOT/WEARABLE-CONNECTED DEVICES, BY REGION, 2023–2030 (USD MILLION) 123
TABLE 30 WEB-BASED PLATFORMS: MAJOR PLAYERS AND OFFERINGS 124
TABLE 31 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR WEB-BASED PLATFORMS,
BY REGION, 2023–2030 (USD MILLION) 125
TABLE 32 EHR/EMR-INTEGRATED SYSTEMS: MAJOR PLAYERS AND OFFERINGS 126
TABLE 33 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR EHR/EMR-INTEGRATED SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 34 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION,
2023–2030 (USD MILLION) 128
TABLE 35 TEXT-BASED INTERACTION: MAJOR PLAYERS AND OFFERINGS 129
TABLE 36 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR TEXT-BASED INTERACTION,
BY REGION, 2023–2030 (USD MILLION) 129
TABLE 37 VOICE-BASED INTERACTION: MAJOR PLAYERS AND OFFERINGS 131
TABLE 38 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR VOICE-BASED INTERACTION,
BY REGION, 2023–2030 (USD MILLION) 131
TABLE 39 MULTIMODAL INTERACTION: MAJOR PLAYERS AND OFFERINGS 132
TABLE 40 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR MULTIMODAL INTERACTION,
BY REGION, 2023–2030 (USD MILLION) 132
TABLE 41 AVATAR/EMOTION-AWARE AI: MAJOR PLAYERS AND OFFERINGS 133
TABLE 42 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR AVATAR/EMOTION-AWARE AI,
BY REGION, 2023–2030 (USD MILLION) 134
TABLE 43 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 136
TABLE 44 CLINICAL APPLICATIONS: MAJOR PLAYERS AND OFFERINGS 137
TABLE 45 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2023–2030 (USD MILLION) 137
TABLE 46 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 138
TABLE 47 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR SYMPTOM ASSESSMENT & TRIAGE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 48 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR PATIENT INTAKE & HISTORY COLLECTION APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 140
TABLE 49 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR MEDICATION MANAGEMENT & REMINDER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 50 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL DECISION SUPPORT APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 51 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL WORKFLOW ASSISTANCE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 52 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR REHABILITATION & RECOVERY TRACKING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 53 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR REMOTE PATIENT MONITORING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 145
TABLE 54 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR OPERATIVE CARE GUIDANCE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 146
TABLE 55 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTH EDUCATION & AWARENESS APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 147
TABLE 56 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR WELLNESS & LIFESTYLE COACHING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 57 NON-CLINICAL APPLICATIONS: MAJOR PLAYERS AND OFFERINGS 149
TABLE 58 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS,
BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 59 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 150
TABLE 60 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR VIRTUAL FRONT DESK & SCHEDULING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 61 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR PATIENT ONBOARDING & NAVIGATION APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 152
TABLE 62 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR AI MEDICAL SCRIBING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 153
TABLE 63 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR AI-DRIVEN BILLING & CLAIMS PROCESSING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 64 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR WORKFORCE/STAFF ASSISTANCE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 155
TABLE 65 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 66 HEALTHCARE PROVIDERS: MAJOR PLAYERS AND OFFERINGS 158
TABLE 67 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 68 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2023–2030 (USD MILLION) 159
TABLE 69 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2023–2030 (USD MILLION) 160
TABLE 70 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 161
TABLE 71 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2023–2030 (USD MILLION) 162
TABLE 72 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HOME HEALTHCARE, BY REGION, 2023–2030 (USD MILLION) 163
TABLE 73 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 164
TABLE 74 HEALTHCARE PAYERS: MAJOR PLAYERS AND OFFERINGS 165
TABLE 75 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PAYERS,
BY REGION, 2023–2030 (USD MILLION) 165
TABLE 76 PATIENTS: MAJOR PLAYERS AND OFFERINGS 166
TABLE 77 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR PATIENTS, BY REGION,
2023–2030 (USD MILLION) 166
TABLE 78 OTHER END USERS: MAJOR PLAYERS AND OFFERINGS 167
TABLE 79 AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 167
TABLE 80 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY REGION,
2023–2030 (USD MILLION) 169
TABLE 81 NORTH AMERICA: MACROECONOMIC INDICATORS 171
TABLE 82 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 83 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 173
TABLE 84 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 173
TABLE 85 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174
TABLE 86 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 87 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 88 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER, 2023–2030 (USD MILLION) 175
TABLE 89 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 90 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 177
TABLE 91 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 177
TABLE 92 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 178
TABLE 93 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 94 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 95 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 179
TABLE 96 US: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 97 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 181
TABLE 98 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 181
TABLE 99 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 182
TABLE 100 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 101 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 102 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 183
TABLE 103 CANADA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 104 EUROPE: MACROECONOMIC INDICATORS 186
TABLE 105 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 186
TABLE 106 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 187
TABLE 107 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 187
TABLE 108 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 188
TABLE 109 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 110 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 111 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 189
TABLE 112 EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 113 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 191
TABLE 114 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 191
TABLE 115 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 192
TABLE 116 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 117 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 118 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 193
TABLE 119 GERMANY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 120 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 195
TABLE 121 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 195
TABLE 122 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 196
TABLE 123 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 124 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 125 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 197
TABLE 126 FRANCE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 127 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 199
TABLE 128 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 199
TABLE 129 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 200
TABLE 130 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 131 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 132 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 201
TABLE 133 UK: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 134 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 203
TABLE 135 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 203
TABLE 136 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 204
TABLE 137 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 138 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 139 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 205
TABLE 140 ITALY: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 141 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 207
TABLE 142 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 207
TABLE 143 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 208
TABLE 144 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 145 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 146 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 209
TABLE 147 SPAIN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 148 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 211
TABLE 149 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION,2023–2030 (USD MILLION) 211
TABLE 150 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 212
TABLE 151 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 152 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 153 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER, 2023–2030 (USD MILLION) 213
TABLE 154 REST OF EUROPE: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 155 ASIA PACIFIC: MACROECONOMIC INDICATORS 215
TABLE 156 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 216
TABLE 157 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 217
TABLE 158 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 217
TABLE 159 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 218
TABLE 160 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 161 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 162 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 219
TABLE 163 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 164 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 221
TABLE 165 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 221
TABLE 166 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 222
TABLE 167 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 168 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 169 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 223
TABLE 170 CHINA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 171 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 225
TABLE 172 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 225
TABLE 173 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 226
TABLE 174 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 175 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 176 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 227
TABLE 177 JAPAN: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 178 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 229
TABLE 179 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 229
TABLE 180 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 230
TABLE 181 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 182 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 183 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 231
TABLE 184 INDIA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 185 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 233
TABLE 186 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 233
TABLE 187 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 234
TABLE 188 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 189 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR
NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 190 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER, 2023–2030 (USD MILLION) 235
TABLE 191 REST OF ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 192 LATIN AMERICA: MACROECONOMIC INDICATORS 237
TABLE 193 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237
TABLE 194 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 238
TABLE 195 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 238
TABLE 196 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239
TABLE 197 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 198 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 199 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER, 2023–2030 (USD MILLION) 240
TABLE 200 LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 201 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 242
TABLE 202 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 242
TABLE 203 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 243
TABLE 204 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 205 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 206 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 244
TABLE 207 BRAZIL: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 208 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 246
TABLE 209 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 246
TABLE 210 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 247
TABLE 211 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 212 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 213 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER,
2023–2030 (USD MILLION) 248
TABLE 214 MEXICO: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 215 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 250
TABLE 216 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 250
TABLE 217 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 251
TABLE 218 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 251
TABLE 219 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR
NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 220 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER, 2023–2030 (USD MILLION) 252
TABLE 221 REST OF LATIN AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 222 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 254
TABLE 223 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 255
TABLE 224 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 255
TABLE 225 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION,2023–2030 (USD MILLION) 256
TABLE 226 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 256
TABLE 227 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 228 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR
NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 229 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY END USER, 2023–2030 (USD MILLION) 258
TABLE 230 MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 231 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 259
TABLE 232 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 260
TABLE 233 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 260
TABLE 234 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 235 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 236 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY END USER, 2023–2030 (USD MILLION) 262
TABLE 237 GCC COUNTRIES: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 238 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 263
TABLE 239 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY MODE OF INTERACTION, 2023–2030 (USD MILLION) 263
TABLE 240 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 264
TABLE 241 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR CLINICAL APPLICATONS, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 242 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR NON-CLINICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 243 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET,
BY END USER, 2023–2030 (USD MILLION) 265
TABLE 244 REST OF MIDDLE EAST & AFRICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 245 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN VIRTUAL HEALTH ASSISTANTS MARKET, JANUARY 2022–JUNE 2025 268
TABLE 246 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: DEGREE OF COMPETITION 272
TABLE 247 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: REGION FOOTPRINT 280
TABLE 248 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: OFFERING FOOTPRINT 281
TABLE 249 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: MODE OF INTERACTION FOOTPRINT 282
TABLE 250 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: APPLICATION FOOTPRINT 283
TABLE 251 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: END-USER FOOTPRINT 284
TABLE 252 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 287
TABLE 253 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: COMPETITIVE BENCHMARKING OF SMES/STARTUPS, BY REGION 287
TABLE 254 DIGITAL HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY APPLICATION 288
TABLE 255 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 288
TABLE 256 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: DEALS, JANUARY 2022–MAY 2025 290
TABLE 257 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: EXPANSIONS,
JANUARY 2022–MAY 2025 291
TABLE 258 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–MAY 2025 292
TABLE 259 TELADOC HEALTH, INC.: COMPANY OVERVIEW 293
TABLE 260 TELADOC HEALTH, INC.: PRODUCTS OFFERED 294
TABLE 261 TELADOC HEALTH, INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 295
TABLE 262 TELADOC HEALTH, INC.: DEALS, JANUARY 2022–JULY 2025 296
TABLE 263 MICROSOFT: COMPANY OVERVIEW 299
TABLE 264 MICROSOFT: PRODUCTS OFFERED 300
TABLE 265 MICROSOFT: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 302
TABLE 266 MICROSOFT: DEALS, JANUARY 2022–JULY 2025 303
TABLE 267 AMAZON.COM, INC.: COMPANY OVERVIEW 305
TABLE 268 AMAZON.COM, INC.: PRODUCTS OFFERED 307
TABLE 269 AMAZON.COM, INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 307
TABLE 270 AMAZON.COM, INC.: DEALS, JANUARY 2022–JULY 2025 308
TABLE 271 SALESFORCE, INC.: COMPANY OVERVIEW 310
TABLE 272 SALESFORCE, INC.: PRODUCTS OFFERED 311
TABLE 273 SALESFORCE, INC.: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2022–JULY 2025 312
TABLE 274 SALESFORCE, INC.: DEALS, JANUARY 2022–JULY 2025 313
TABLE 275 INFERMEDICA: COMPANY OVERVIEW 316
TABLE 276 INFERMEDICA: PRODUCTS OFFERED 316
TABLE 277 INFERMEDICA: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 317
TABLE 278 INFERMEDICA: DEALS, JANUARY 2022–JULY 2025 317
TABLE 279 INFERMEDICA: EXPANSIONS, JANUARY 2022–JULY 2025 318
TABLE 280 EGAIN CORPORATION: COMPANY OVERVIEW 321
TABLE 281 EGAIN CORPORATION: PRODUCTS OFFERED 322
TABLE 282 EGAIN CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 323
TABLE 283 VERINT SYSTEMS INC.: COMPANY OVERVIEW 325
TABLE 284 VERINT SYSTEMS INC.: PRODUCTS OFFERED 327
TABLE 285 VERINT SYSTEMS INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 328
TABLE 286 VERINT SYSTEMS INC.: DEALS, JANUARY 2022–JULY 2025 328
TABLE 287 LIVEPERSON: COMPANY OVERVIEW 331
TABLE 288 LIVEPERSON: PRODUCTS OFFERED 332
TABLE 289 LIVEPERSON: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 333
TABLE 290 LIVEPERSON: DEALS, JANUARY 2022–JULY 2025 334
TABLE 291 NICE: COMPANY OVERVIEW 336
TABLE 292 NICE: PRODUCTS OFFERED 337
TABLE 293 NICE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2022–JULY 2025 338
TABLE 294 NICE: DEALS, JANUARY 2022–JULY 2025 339
TABLE 295 TECKEL MEDICAL: COMPANY OVERVIEW 342
TABLE 296 TECKEL MEDICAL: PRODUCTS OFFERED 342
TABLE 297 TECKEL MEDICAL: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 343
TABLE 298 TECKEL MEDICAL: DEALS, JANUARY 2022–JULY 2025 343
TABLE 299 TECKEL MEDICAL: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 345
TABLE 300 MOVATE: COMPANY OVERVIEW 347
TABLE 301 MOVATE: PRODUCTS OFFERED 347
TABLE 302 MOVATE: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 348
TABLE 303 MOVATE: DEALS, JANUARY 2022–JULY 2025 349
TABLE 304 FEEBRIS LTD.: COMPANY OVERVIEW 350
TABLE 305 FEEBRIS LTD.: PRODUCTS OFFERED 351
TABLE 306 FEEBRIS LTD.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 351
TABLE 307 FEEBRIS LTD.: DEALS, JANUARY 2022–JULY 2025 352
TABLE 308 HEALTHTAP, INC.: COMPANY OVERVIEW 353
TABLE 309 HEALTHTAP, INC.: PRODUCTS OFFERED 354
TABLE 310 HEALTHTAP, INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 354
TABLE 311 HEALTHTAP, INC.: DEALS, JANUARY 2022–JULY 2025 355
TABLE 312 ADA HEALTH: COMPANY OVERVIEW 356
TABLE 313 ADA HEALTH: PRODUCTS OFFERED 357
TABLE 314 ADA HEALTH: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 357
TABLE 315 ADA HEALTH: DEALS, JANUARY 2022–JULY 2025 358
TABLE 316 BUOY HEALTH, INC.: COMPANY OVERVIEW 360
TABLE 317 BUOY HEALTH, INC.: PRODUCTS OFFERED 361
TABLE 318 BUOY HEALTH, INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 362
TABLE 319 BUOY HEALTH, INC.: DEALS, JANUARY 2022–JULY 2025 362
TABLE 320 WOEBOT HEALTH: COMPANY OVERVIEW 364
TABLE 321 WOEBOT HEALTH: PRODUCTS OFFERED 365
TABLE 322 WOEBOT HEALTH: DEALS, JANUARY 2022–JULY 2025 365
TABLE 323 WOEBOT HEALTH: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 366
TABLE 324 FABRIC LABS, INC.: COMPANY OVERVIEW 367
TABLE 325 FABRIC LABS, INC.: PRODUCTS OFFERED 368
TABLE 326 FABRIC LABS, INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 369
TABLE 327 FABRIC LABS, INC.: DEALS, JANUARY 2022–JULY 2025 370
TABLE 328 FABRIC LABS, INC.: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 371
TABLE 329 WYSA LTD.: COMPANY OVERVIEW 372
TABLE 330 WYSA LTD.: PRODUCTS OFFERED 373
TABLE 331 WYSA LTD.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 374
TABLE 332 WYSA LTD.: DEALS, JANUARY 2022–JULY 2025 375
TABLE 333 WELL HEALTH TECHNOLOGIES CORP: COMPANY OVERVIEW 376
TABLE 334 WELL HEALTH TECHNOLOGIES CORP: PRODUCTS OFFERED 377
TABLE 335 WELL HEALTH TECHNOLOGIES CORP: PRODUCT LAUNCHES,
JANUARY 2022–JULY 2025 378
TABLE 336 WELL HEALTH TECHNOLOGIES CORP: DEALS, JANUARY 2022–JULY 2025 380
TABLE 337 HEALTHILY LTD: COMPANY OVERVIEW 381
TABLE 338 HEALTHILY LTD: PRODUCTS OFFERED 382
TABLE 339 HEALTHILY LTD: PRODUCT LAUNCHES & UPGRADES, JANUARY 2022–JULY 2025 382
TABLE 340 HEALTHILY LTD: DEALS, JANUARY 2022–JULY 2025 383
TABLE 341 ORBITA, INC.: COMPANY OVERVIEW 385
TABLE 342 ORBITA, INC.: PRODUCTS OFFERED 386
TABLE 343 ORBITA, INC: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 387
TABLE 344 ORBITA, INC.: DEALS, JANUARY 2022–JULY 2025 387
TABLE 345 5 HEALTH HOLDINGS INC.: COMPANY OVERVIEW 389
TABLE 346 5 HEALTH HOLDINGS INC.: PRODUCTS OFFERED 390
TABLE 347 5 HEALTH HOLDINGS INC: DEALS, JANUARY 2022–JULY 2025 391
TABLE 348 HYRO AI INC.: COMPANY OVERVIEW 392
TABLE 349 HYRO AI INC.: PRODUCTS OFFERED 393
TABLE 350 HYRO AI INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 394
TABLE 351 HYRO AI INC.: DEALS, JANUARY 2022–JULY 2025 394
TABLE 352 EMPOWER HEALTH: COMPANY OVERVIEW 396
TABLE 353 EMPOWER HEALTH: PRODUCTS OFFERED 397
TABLE 354 EMPOWER HEALTH: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 397
TABLE 355 EMPOWER HEALTH: DEALS, JANUARY 2022–JULY 2025 398
TABLE 356 VERADIGM LLC: COMPANY OVERVIEW 399
TABLE 357 VERADIGM LLC: PRODUCTS OFFERED 401
TABLE 358 VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 402
TABLE 359 VERADIGM LLC: DEALS, JANUARY 2022–JULY 2025 402
TABLE 360 K HEALTH: COMPANY OVERVIEW 403
TABLE 361 K HEALTH: PRODUCTS OFFERED 403
TABLE 362 K HEALTH: DEALS, JANUARY 2022–JULY 2025 405

LIST OF FIGURES

FIGURE 1 AI IN VIRTUAL HEALTH ASSISTANTS MARKET SEGMENTATION & REGIONAL SCOPE 35
FIGURE 2 RESEARCH DESIGN 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 43
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 45
FIGURE 5 BOTTOM-UP APPROACH 46
FIGURE 6 TOP-DOWN APPROACH 47
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN AI IN VIRTUAL
HEALTH ASSISTANTS INDUSTRY 48
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 50
FIGURE 10 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY OFFERING,
2025 VS. 2030 (USD MILLION) 53
FIGURE 11 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY MODE OF INTERACTION,
2025 VS. 2030 (USD MILLION) 54
FIGURE 12 AI IN VIRTUAL HEALTH ASSISTANTS MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 55
FIGURE 13 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: GEOGRAPHICAL SNAPSHOT 56
FIGURE 14 RAPID AI ADVANCEMENTS AND WIDESPREAD SMARTPHONE ADOPTION TO BOOST MARKET GROWTH 57
FIGURE 15 CLINICAL APPLICATIONS IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 58
FIGURE 16 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED ECONOMIES DURING FORECAST PERIOD 60
FIGURE 18 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
FIGURE 20 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: ECOSYSTEM ANALYSIS 72
FIGURE 21 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: SUPPLY CHAIN ANALYSIS 76
FIGURE 22 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 90
FIGURE 23 JURISDICTION AND TOP APPLICANT ANALYSIS OF AI IN VIRTUAL
HEALTH ASSISTANT SOLUTIONS 93
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN VIRTUAL HEALTH ASSISTANTS MARKET (JANUARY 2015 TO MAY 2025) 94
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 96
FIGURE 26 KEY BUYING CRITERIA FOR END USERS 97
FIGURE 27 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: INVESTOR DEALS AND
FUNDING LANDSCAPE 104
FIGURE 28 MARKET POTENTIAL OF AI/GENERATIVE AI IN VIRTUAL HEALTH ASSISTANTS ACROSS INDUSTRIES 107
FIGURE 29 PRICE IMPACT ANALYSIS 117
FIGURE 30 NORTH AMERICA: AI IN VIRTUAL HEALTH ASSISTANTS MARKET SNAPSHOT 172
FIGURE 31 ASIA PACIFIC: AI IN VIRTUAL HEALTH ASSISTANTS MARKET SNAPSHOT 216
FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN VIRTUAL HEALTH ASSISTANTS MARKET, 2020–2024 270
FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN VIRTUAL HEALTH
ASSISTANTS MARKET, 2024 271
FIGURE 34 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 274
FIGURE 35 EV/EBITDA OF KEY VENDORS 275
FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 275
FIGURE 37 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: KEY PLAYERS, 2024 276
FIGURE 38 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 278
FIGURE 39 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: COMPANY FOOTPRINT 279
FIGURE 40 AI IN VIRTUAL HEALTH ASSISTANTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 286
FIGURE 41 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2024) 294
FIGURE 42 MICROSOFT: COMPANY SNAPSHOT (2024) 300
FIGURE 43 AMAZON.COM, INC.: COMPANY SNAPSHOT (2024) 306
FIGURE 44 SALESFORCE, INC.: COMPANY SNAPSHOT (2024) 311
FIGURE 45 EGAIN CORPORATION: COMPANY SNAPSHOT (2024) 321
FIGURE 46 VERINT SYSTEMS INC.: COMPANY SNAPSHOT (2024) 326
FIGURE 47 LIVEPERSON: COMPANY SNAPSHOT (2024) 331
FIGURE 48 NICE: COMPANY SNAPSHOT (2024) 337
FIGURE 49 WELL HEALTH TECHNOLOGIES CORP: COMPANY SNAPSHOT (2024) 377
FIGURE 50 VERADIGM LLC: COMPANY SNAPSHOT (2022) 400